Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ARTL Artelo Biosciences Inc

1,1642

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:27:08

Verzögert um 15 Minuten

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

null

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Artelo Biosciences Charts.

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Artelo Biosciences Charts.

News Artelo Biosciences Inc

Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12
Montag 13 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia
Montag 9 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
Montag 18 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 8 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
Dienstag 5 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th
Mittwoch 9 Oktober 2024 (4 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Mittwoch 4 September 2024 (5 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
Dienstag 13 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
Montag 15 Juli 2024 (6 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
Mittwoch 3 Juli 2024 (7 Monate vor) • GlobeNewswire Inc.

Weitere Artelo Biosciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen